Structural transformations of oligomeric intermediates in the fibrillation of the immunoglobulin light chain LEN

被引:70
作者
Souillac, PO [1 ]
Uversky, VN [1 ]
Fink, AL [1 ]
机构
[1] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA
关键词
D O I
10.1021/bi034652m
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
LEN is a kappaIV immunoglobulin light chain variable domain from a patient suffering from multiple myeloma but with no evidence of amyloid fibrils. However, fibrils are formed when LEN solutions are agitated under mildly destabilizing conditions. Surprisingly, an inverse concentration dependence was observed on the kinetics of fibril formation because of the formation of off-pathway soluble oligomers at high protein concentration. Despite the fact that most of the protein is present in the off-pathway intermediates at relatively early times of aggregation, eventually all the protein forms fibrils. Thus, a structural rearrangement from the non fibril-prone off-pathway oligomers to a more fibril-prone species must occur. A variety of techniques were used to monitor changes in the size, secondary structure, solvent accessibility, and intrinsic stability of the oligomers, as a function of incubation time. The structural rearrangement was accompanied by a significant increase of disordered secondary structure, an increase in solvent accessibility, and a decrease in intrinsic stability of the soluble oligomeric species. We conclude that fibrils arise from the oligomers containing a less stable conformation of LEN, either directly or via dissociation. This is the first fibrillating system in which soluble off-pathway oligomeric intermediates have been shown to be the major transient species and in which fibrillation occurs from a relatively unfolded conformation present in these intermediates.
引用
收藏
页码:8094 / 8104
页数:11
相关论文
共 31 条
[1]   MECHANISMS OF DISEASE - MONOCLONAL IMMUNOGLOBULIN DEPOSITION - AMYLOIDOSIS, LIGHT CHAIN DEPOSITION DISEASE, AND LIGHT AND HEAVY-CHAIN DEPOSITION DISEASE [J].
BUXBAUM, J .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (02) :323-346
[2]  
De Laureto PP, 1999, PROTEIN SCI, V8, P2290
[3]   Monitoring structural stability of trypsin inhibitor at the submolecular level by amide-proton exchange using Fourier transform infrared spectroscopy: A test case for more general application [J].
deJongh, HHJ ;
Goormaghtigh, E ;
Ruysschaert, JM .
BIOCHEMISTRY, 1997, 36 (44) :13593-13602
[4]   Amide-proton exchange of water-soluble proteins of different structural classes studied at the submolecular level by infrared spectroscopy [J].
deJongh, HHJ ;
Goormaghtigh, E ;
Ruysschaert, JM .
BIOCHEMISTRY, 1997, 36 (44) :13603-13610
[5]  
EFTINK MR, 1982, BIOCHEMISTRY-US, V21, P117, DOI 10.1021/bi00530a021
[6]   Probing the conformational state of apomyoglobin by limited proteolysis [J].
Fontana, A ;
Zambonin, M ;
deLaureto, PP ;
DeFilippis, V ;
Clementi, A ;
Scaramella, E .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 266 (02) :223-230
[7]   Acrylamide quenching of apo- and holo-α-lactalbumin in guanidine hydrochloride [J].
France, RM ;
Grossman, SH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 269 (03) :709-712
[8]   Assembly of Aβ amyloid protofibrils:: An in vitro model for a possible early event in Alzheimer's disease [J].
Harper, JD ;
Wong, SS ;
Lieber, CM ;
Lansbury, PT .
BIOCHEMISTRY, 1999, 38 (28) :8972-8980
[9]   Variable domain structure of κIV human light chain Len:: High homology to the murine light chain McPC603 [J].
Huang, DB ;
Chang, CH ;
Ainsworth, C ;
Johnson, G ;
Solomon, A ;
Stevens, FJ ;
Schiffer, M .
MOLECULAR IMMUNOLOGY, 1997, 34 (18) :1291-1301
[10]   The structural aspects of limited proteolysis of native proteins [J].
Hubbard, SJ .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1998, 1382 (02) :191-206